Compare IZEA & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZEA | CSBR |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.8M | 90.0M |
| IPO Year | N/A | 1986 |
| Metric | IZEA | CSBR |
|---|---|---|
| Price | $4.41 | $6.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 55.7K | 21.8K |
| Earning Date | 11-12-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | $36,176,492.00 | ★ $58,424,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | $15.91 | $11.51 |
| P/E Ratio | ★ N/A | $38.68 |
| Revenue Growth | 7.12 | ★ 9.06 |
| 52 Week Low | $1.68 | $5.59 |
| 52 Week High | $5.86 | $11.99 |
| Indicator | IZEA | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 50.08 |
| Support Level | $4.30 | $6.52 |
| Resistance Level | $4.74 | $6.79 |
| Average True Range (ATR) | 0.17 | 0.37 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 15.00 | 46.22 |
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.